When treating cancer, researchers are always searching for ways to remove cancer cells while minimizing damage to the rest of the body. One possible approach is to find processes unique to cancer cells, and which would allow specific targeting. If…
Read MoreNovel hybrid device to boost research on metastatic process of breast cancer cells
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells traveling from breast to bone and fast screen new drugs against it. The spread of cancer cells to other parts of the…
Read MoreRemoving microRNAs from triple-negative breast cancer cells can reverse its spread
A new study led by the University of Westminster shows that removing small genetic parts of our genomes called microRNAs from triple negative breast cancer cells can reverse its spread. The study, published in the International Journal of Molecular Sciences,…
Read MoreBetter diagnosis for brain cancer
A research team from both Scottish and UK institutions using infrared spectroscopy at Diamond Light Source reports a major advance in brain tumor diagnosis made by. This will enable non-invasive diagnoses of primary brain tumors (gliomas) and accelerate results as…
Read MoreFirmagon
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Firmagon® Degarelix (as acetate) Powder and Solvent for Injection, depot Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Firmagon. It…
Read MoreAmlodipine/Valsartan/HCT Novartis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VALSARTAN/AMLODIPINE/HCT NOVARTIS® 5/160/12.5, 5/160/25, 10/160/12.5, 10/160/25, 10/320/25 amlodipine besilate/valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about AMLODIPINE/VALSARTAN/HCT NOVARTIS. It…
Read MoreStudy shows aspirin before a diagnosis may lower colorectal cancer mortality
A new study finds that long-term aspirin use before a diagnosis of colorectal cancer (CRC) may be associated with lower CRC-specific mortality. The report that appears in JNCI: The Journal of the National Cancer Institute, suggests that the findings for…
Read MoreAlecensa
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALECENSA® ROCALECE10720 alectinib hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Alecensa. It does not contain all the available…
Read MoreAprepitant APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APREPITANT APOTEX aprepitant Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available…
Read MoreAPO-Zoledronic Acid
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-ZOLEDRONIC ACID SOLUTION FOR INFUSION Zoledronic acid monohydrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about zoledronic acid 4mg/5mL. It…
Read More